A decrease in remodeling accounts for the accumulation of arachidonic acid in murine mast cells undergoing apoptosis.
The goal of this study was to examine arachidonic acid (AA) metabolism by murine bone marrow-derived mast cells (BMMC) during apoptosis induced by cytokine depletion. BMMC deprived of cytokines for 12-48 h displayed apoptotic characteristics. During apoptosis, levels of AA, but not other unsaturated fatty acids, correlated with the percentage of apoptotic cells. A decrease in both cytosolic phospholipase A(2) expression and activity indicated that cytosolic phospholipase A(2) did not account for AA mobilization during apoptosis. Free AA accumulation is also unlikely to be due to decreases in 5-lipoxygenase and/or cyclooxygenase activities, since BMMC undergoing apoptosis produced similar amounts of leukotriene B(4) and significantly greater amounts of PGD(2) than control cells. Arachidonoyl-CoA synthetase and CoA-dependent transferase activities responsible for incorporating AA into phospholipids were not altered during apoptosis. However, there was an increase in arachidonate in phosphatidylcholine (PC) and neutral lipids concomitant with a 40.7 +/- 8.1% decrease in arachidonate content in phosphatidylethanolamine (PE), suggesting a diminished capacity of mast cells to remodel arachidonate from PC to PE pools. Further evidence of a decrease in AA remodeling was shown by a significant decrease in microsomal CoA-independent transacylase activity. Levels of lyso-PC and lyso-PE were not altered in cells undergoing apoptosis, suggesting that the accumulation of lysophospholipids did not account for the decrease in CoA-independent transacylase activity or the induction of apoptosis. Together, these data suggest that the mole quantities of free AA closely correlated with apoptosis and that the accumulation of AA in BMMC during apoptosis was mediated by a decreased capacity of these cells to remodel AA from PC to PE.
Fonteh
A N
AN
Department of Internal Medicine, Pulmonary and Critical Care Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27154, USA. afonteh@wfubmc.edu
LaPorte
T
T
Swan
D
D
McAlexander
M A
MA
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D016718:Arachidonic Acid / Q000378:metabolism*; D001854:Bone Marrow Cells / Q000166:cytology; D002478:Cells, Cultured; D003066:Coenzyme A Ligases / Q000378:metabolism; D003470:Culture Media; D016207:Cytokines / Q000494:pharmacology*; D004247:DNA / Q000096:biosynthesis; D015777:Eicosanoids / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D007377:Interleukin-3 / Q000494:pharmacology; D007700:Kinetics; D015227:Lipid Peroxidation / Q000187:drug effects*; D008407:Mast Cells / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D008808:Mice, Inbred CBA; D008956:Models, Chemical; D010713:Phosphatidylcholines / Q000378:metabolism; D010714:Phosphatidylethanolamines / Q000378:metabolism; D010741:Phospholipases A / Q000378:metabolism; D019089:Stem Cell Factor / Q000494:pharmacology
D003470:Culture Media; D016207:Cytokines; D015777:Eicosanoids; D005230:Fatty Acids, Nonesterified; D007377:Interleukin-3; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D019089:Stem Cell Factor; D016718:Arachidonic Acid; D004247:DNA; D010741:Phospholipases A; D003066:Coenzyme A Ligases; C033896:arachidonate - CoA ligase